MedTrace Logo

Otoacoustic Emissions in Different Blood Types

NCT06326866 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2024-03-26

No results posted yet for this study

Summary

The objective of this study is to examine whether ABO and Rhesus (Rh) blood group systems have an association with distortion product otoacoustic emission (DPOAE) and transient otoacoustic emission (TEOAE) amplitudes with the hypothesis of blood groups may affect hearing thresholds.

Conditions

  • Hearing Loss, Cochlear

Interventions

DIAGNOSTIC_TEST

Otoacoustic emissions (non-invasive)

There is no invasive intervention in the study. Individuals with predetermined blood types will be included in the study.

Sponsors & Collaborators

  • Istanbul University - Cerrahpasa

    lead OTHER

Principal Investigators

  • Eyyup Kara, PhD · Istanbul University - Cerrahpasa

Eligibility

Min Age
18 Years
Max Age
26 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-07
Primary Completion
2024-03-12
Completion
2024-03-18

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06326866 on ClinicalTrials.gov